Back to Search
Start Over
Loss-of-function mutation in myostatin reduces tumor necrosis factor α production and protects liver against obesity-induced insulin resistance
- Source :
- Diabetes. May 2009, Vol. 58 Issue 5, p1133, 11 p.
- Publication Year :
- 2009
-
Abstract
- Myostatin (Mstn; also called Gdf-8) is a transforming growth factor-β family member that is predominantly expressed in skeletal muscle tissue (1,2). Mstn negatively regulates muscle mass (2,3) and is a [...]<br />OBJECTIVE--Insulin resistance develops in tandem with obesity. Ablating myostatin (Mstn) prevents obesity, so we investigated if Mstn deficiency could improve insulin sensitivity. A loss-of-function mutation ([Mstn.sup.Ln]) in either one or both alleles of the Mstn gene shows how Mstn deficiency protects whole-body insulin sensitivity. RESEARCH DESIGN AND METHODS--[Mstn.sup.Ln/Ln] mice were weaned onto a high-fat diet (HFD) or standard diet. HFD-fed [Mstn.sup.Ln/Ln] mice exhibited high lean, low-fat body compositions compared with wild types. Wild-type and heterozygous and homozygous mutant mice were bled to determine basal levels of insulin, glucose, and homeostasis model assessment of insulin resistance. To evaluate postprandial insulin sensitivity between animals of a similar size, glucose and insulin tolerance tests and hyperinsulinemic-euglycemic clamp studies were performed with heterozygous and homozygous mutant mice. Quantitative RT-PCR quantified TNF[proportional], IL-6, IL-1β, F4/80, GPR43, and CD36 expression in muscle, fat, and liver. Histological analysis measured hepatosteatosis. RESULTS--Homozygous mutants were glucose tolerant and protected against overall insulin resistance compared with heterozygous mice. Hyperinsulinemic-euglycemic clamp studies revealed a dramatically improved glucose infusion rate, glucose disposal rate, and hepatic glucose production in 11-month-old [Mstn.sup.Ln/Ln] mice on an HFD. Improvements to muscle and liver insulin sensitivity (~200-400%) correlated with 50-75% decreased tumor necrosis factor (TNF)α production and coincided with severe Mstn deficiency. Hepatosteatosis appeared to be ameliorated. Short-term treatment of [Mstn.sup.Ln/Ln] mice with recombinant Mstn led to increased plasma TNFα and insulin resistance. CONCLUSIONS--We find that severe Mstn deficiency caused by Ln (lean) mutations in HFD-fed mice protects muscle and liver against obesity-induced insulin resistance. Diabetes 58:1133-1143, 2009
- Subjects :
- Prevention
Complications and side effects
Research
Genetic aspects
Risk factors
Health aspects
Obesity -- Complications and side effects -- Research -- Prevention -- Risk factors -- Genetic aspects
Myostatin -- Health aspects -- Genetic aspects -- Research
Tumor necrosis factor -- Health aspects -- Research -- Genetic aspects
Gene mutation -- Health aspects -- Research -- Genetic aspects
Insulin resistance -- Risk factors -- Prevention -- Research -- Complications and side effects -- Genetic aspects
Gene mutations -- Health aspects -- Research -- Genetic aspects
Subjects
Details
- Language :
- English
- ISSN :
- 00121797
- Volume :
- 58
- Issue :
- 5
- Database :
- Gale General OneFile
- Journal :
- Diabetes
- Publication Type :
- Periodical
- Accession number :
- edsgcl.199463973